Dr. Emma Burkitt-Wright joined the NSA as Medical Advisor Trustee in July 2024. She is a consultant clinical geneticist in the Manchester Centre for Genomic Medicine. Her special interests lie predominantly in disorders of the Ras-MAPK pathway, including Noonan Syndrome, Costello and cardio-facio-cutaneous syndromes and Neurofibromatosis Type I. It was the molecular basis and clinical phenotypes of these that were the primary focus of her PhD. She also a member of the professional advisory boards of the Noonan Syndrome Association, Costello Syndrome Family Network and CFC International.
